Brief: bluebird bio Confirms Participation in Center for Medicare and Medicaid Innovation (CMMI) Cell and Gene Therapy Access Model
04/12/2024 13:53
Dec 4 (Reuters) - bluebird bio Inc BLUE.O :
* BLUEBIRD BIO CONFIRMS PARTICIPATION IN CENTER FOR MEDICARE
AND
MEDICAID INNOVATION (CMMI) CELL AND GENE THERAPY ACCESS MODEL
* BLUEBIRD BIO INC - STATES CAN OPT IN TO AGREEMENT UNTIL
FEBRUARY
28, 2025
Source text: ID:nBw7HhvfZa
Further company coverage: BLUE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on bluebird bio
See all newsBrief: Bluebird Bio Announces Completion Of Acquisition By Carlyle And SK Capital
Brief: Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
Brief: Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment